Related Experiment Videos
Radiotherapy in soft-tissue sarcoma
Lancet (London, England)
|December 21, 2002
Summary
No abstract available in PubMed .
Related Concept Videos
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Effect of COVID-19 NHS breast screening pause on breast cancer presentation and management: an insight into overdiagnosis.
JRSM open·2026
Same author
A novel methodology using direct patient contact and UK national registries to collect long-term data from randomised trials: TARGIT-X - an extended follow-up study of the TARGIT-A trial of targeted intraoperative radiotherapy for breast cancer.
Health technology assessment (Winchester, England)·2026
Same author
Design and development of a portable multiwavelength LED-based diffuse reflectance spectroscopy tool for rapid breast cancer identification.
Scientific reports·2025
Same author
Menopausal hormone therapy for breast cancer patients: what is the current evidence?
Menopause (New York, N.Y.)·2025
Same author
The evolution of targeted intra operative radiotherapy in early breast cancer.
Journal of cancer research and clinical oncology·2025
Same author
Qualitative exploration of patients' experiences with Intrabeam TARGeted Intraoperative radioTherapy (TARGIT-IORT) and External-Beam RadioTherapy Treatment (EBRT) for breast cancer.
BMJ open·2024
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026